{"name":"Hatem AbuHashim","slug":"hatem-abuhashim","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Hematology","slug":"hematology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Iron bisglycinate Oral Tablet","genericName":"Iron bisglycinate Oral Tablet","slug":"iron-bisglycinate-oral-tablet","indication":"Iron deficiency anemia","status":"phase_3"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Terconazole Vaginal Suppository","genericName":"Terconazole Vaginal Suppository","slug":"terconazole-vaginal-suppository","indication":"Vulvovaginal candidiasis (yeast infection)","status":"marketed"}]}],"pipeline":[{"name":"Iron bisglycinate Oral Tablet","genericName":"Iron bisglycinate Oral Tablet","slug":"iron-bisglycinate-oral-tablet","phase":"phase_3","mechanism":"Iron bisglycinate provides bioavailable iron in a chelated form that is absorbed in the gastrointestinal tract to replenish iron stores and support hemoglobin synthesis.","indications":["Iron deficiency anemia","Iron supplementation in pregnancy or lactation"],"catalyst":""},{"name":"Terconazole Vaginal Suppository","genericName":"Terconazole Vaginal Suppository","slug":"terconazole-vaginal-suppository","phase":"marketed","mechanism":"Terconazole inhibits fungal cell membrane synthesis by blocking lanosterol 14α-demethylase, disrupting ergosterol production in Candida species.","indications":["Vulvovaginal candidiasis (yeast infection)"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":1,"marketed":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}